DURATION OF USE OF EXTENDED-RELEASE (ER) OXYCODONE, ER MORPHINE, AND CELECOXIB AMONG ADULTS WITH CANCER AND NON-CANCER PAIN

被引：0
|
作者：
DeVeaugh-Geiss, Angela [1 ]
Kadakia, Aditi [1 ]
Chilcoat, Howard D. [1 ]
Coplan, Paul [1 ]
机构：
[1] Purdue Pharma LP, Stamford, CT USA
来源：
JOURNAL OF GENERAL INTERNAL MEDICINE | 2013年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：S66 / S67
页数：2
相关论文
共 50 条
  • [1] Duration of use of extended-release oxycodone and morphine among adults with cancer and non-cancer pain
    DeVeaugh-Geiss, A.
    Kadakia, A.
    Chilcoat, H.
    Coplan, P.
    [J]. JOURNAL OF PAIN, 2013, 14 (04): : S75 - S75
  • [2] Dose and duration of use among commercially insured adults prescribed immediate-release (IR) or extended-release (ER) oxycodone
    DeVeaugh-Geiss, Angela
    Coplan, Paul
    Kadakia, Aditi
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 130 - 130
  • [3] Laxative Use in Inpatients on Oxycodone/Naloxone Prolonged Release and Oxycodone Prolonged Release for Cancer and Non-cancer Pain
    Patel, Joanne
    Lucas, Catherine J.
    Margalit, Maxwell
    Martin, Jennifer H.
    [J]. JOURNAL OF PAIN & PALLIATIVE CARE PHARMACOTHERAPY, 2018, 32 (2-3) : 116 - 123
  • [4] Abuse of Extended-Release (ER) and Immediate-Release Oxycodone in Kentucky Following Introduction of Reformulated ER Oxycodone
    DeVeaugh-Geiss, A.
    Leukefeld, C.
    Havens, J.
    Coplan, P.
    Chilcoat, H.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 447 - 447
  • [5] Extended-Release Hydrocodone (Hysingla ER) for Pain
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1468): : 5 - 6
  • [6] Extended-Release Hydrocodone (Zohydro ER) for Pain
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2014, 56 (1444): : 45 - 46
  • [7] Efficacy and Safety of Once-Daily Extended-Release (ER) Hydrocodone in Individuals Previously Receiving ER Morphine for Chronic Pain
    Broglio, Kathleen
    Pergolizzi, Joseph
    Kowalski, Maribeth
    Lynch, Shau Yu
    He, Ellie
    Wen, Warren
    [J]. PAIN PRACTICE, 2017, 17 (03) : 382 - 391
  • [8] Review of extended-release formulations of Tramadol for the management of chronic non-cancer pain: focus on marketed formulations
    Kizilbash, Arshi
    Cu'ong Ngo-Minh
    [J]. JOURNAL OF PAIN RESEARCH, 2014, 7 : 149 - 161
  • [9] Controlled-release oxycodone and morphine in cancer related pain
    Heiskanen, T
    Kalso, E
    [J]. PAIN, 1997, 73 (01) : 37 - 45
  • [10] A randomized, double-blind study of hydromorphone hydrochloride extended-release tablets versus oxycodone hydrochloride extended-release tablets for cancer pain: efficacy and safety in Japanese cancer patients (EXHEAL: a Phase III study of EXtended-release HydromorphonE for cAncer pain reLief)
    Inoue, Satoshi
    Saito, Yoji
    Tsuneto, Satoru
    Aruga, Etsuko
    Ide, Azusa
    Kakurai, Yasuyuki
    [J]. JOURNAL OF PAIN RESEARCH, 2017, 10 : 1953 - 1961
12345